Comirnaty Injection, Suspension
Product Images NDC 0069-2501
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Comirnaty (NDC 0069-2501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (Comirnaty 02)
Image (Comirnaty 03)
Image (Comirnaty 04)
Image (Comirnaty 05)
Logo (Comirnaty 06)
Principal Display Panel (0.3 mL Vial Label)
Principal Display Panel (10 Vial Carton)
This is a product label for the COVID-19 vaccine, Commirnaty, which is an mRNA medicine, with NDC code 0069-2025-10. The medicine comes in 10 multiple dose vials, with each vial containing 6 doses of 0.3 mL. It is not to be diluted and is given through injections for intramuscular use. There are several manufacturing and distributive details and information provided on the label.*
Principal Display Panel (25 Vial Carton)
This is a product description for COMIRNATY® COVID-19 vaccine. It is an mRNA vaccine that is administered through intramuscular injection and should not be diluted. The vaccine is stored and transported between -90°C to -80°C (-130°F to -112°F) and it can be stored at C 0 8°C (35°F to 46°F) for up to 10 weeks. Each multiple dose vial contains 6 doses of 0.3 mL and the manufacturer is Pfizer in New York, with the license number 2229.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.